Brief: Consun Pharmaceutical announces further acquisition of about 5.42% equity interest in Guangxi Yulin Pharmaceutical
Aug 16 (Reuters) - Consun Pharmaceutical Group Ltd 1681.HK : * Connected transaction - further acquisition of approximately 5.42% equity interest in Guangxi Yulin Pharmaceutical Group Co., Ltd. 1681.HK * Unit has entered into the equity transfer agreements with the seventh round vendors on 15 August 2016 and 16 August 2016 * Says consideration to be funded by internal resources of the group * Deal for consideration of approximately RMB47.3 million * Source text for Eikon urn:newsml:reuters.com:*:nHKS376KzP ((Further company coverage: 1681.HK )) ((Bangalore.newsroom@thomsonreuters.com))
Recent news on Consun Pharmaceutical
See all newsChina's Consun Pharmaceutical H1 revenue rises on sales network expansion
Brief: Consun Pharmaceutical Says Unit To Invest RMB191.4 Mln In Shanghai Huamao Pharmaceutical
Brief: Consun Pharmaceutical Group Announces Share Repurchase Program Up To HKD200 Million
Brief: Consun Pharmaceutical Logs FY Revenue RMB 3,420 Mln
Brief: Consun Pharmaceutical Says Executive Director Zhu Quan Redesignated As Non-Executive Director